DD

Director Director DIN 09394134
DIN 09394134 First appointment Nov 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Deep Das

Data last updated:

Deep Das was a Director at Unolyn Pharma International Private Limited (2022) and Director at Acure Pharma Private Limited (2021–2022). The companies operate in Chemicals.

DIN 09394134
Primary Designation Director
Industry Chemicals
First Appointment 22 Nov 2021

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director19 Jan 20222022Active
Acure Pharma Private Limited U24299WB2021PTC249731
Director22 Nov 20212021Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Unolyn Pharma International Private Limited
Acure Pharma Private Limited
Premium access

Shareholding and investment profile for Deep Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deep Das

Deep Das was first appointed on 22 Nov 2021 as Director at Acure Pharma Private Limited. The most recent appointment on record is 19 Jan 2022 at Unolyn Pharma International Private Limited.

Deep Das held 2 earlier board appointments: Unolyn Pharma International Private Limited (Director, 19 Jan 2022 to 30 Mar 2022); Acure Pharma Private Limited (Director, 22 Nov 2021 to 30 Mar 2022).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available